Zhong Guo Jing Ji Wang·2025-10-20 07:36Core Insights - The company reported a revenue of 103 million yuan in the first half of 2025, representing a year-on-year increase of 34.65% [1] - The net profit attributable to shareholders was -14.96 million yuan, a decrease of 286.35% compared to the same period last year [2] - The company experienced a negative cash flow from operating activities amounting to -7.39 million yuan [2] Financial Performance - Revenue for the first half of 2025 was 102,845,831.15 yuan, up from 76,379,907.89 yuan in the same period last year, marking a 34.65% increase [2] - Total profit for the period was -17,839,223.06 yuan, a decline of 354.84% compared to a profit of 7,000,091.27 yuan last year [2] - The net profit after deducting non-recurring gains and losses was -16,666,112.13 yuan, down 465.16% from 4,564,028.49 yuan in the previous year [2] - The cash flow from operating activities was -7,387,017.13 yuan, compared to -1,974,554.24 yuan in the same period last year [2] Previous Year Comparison - In 2024, the company achieved total revenue of 185.32 million yuan, a 10.14% increase from 168.25 million yuan in 2023 [3] - The net profit attributable to shareholders in 2024 was 15.27 million yuan, up 69.99% from 8.98 million yuan in 2023 [3] - The net profit after deducting non-recurring gains and losses was 8.80 million yuan, a significant increase of 234.99% from 2.63 million yuan in 2023 [3] - The cash flow from operating activities in 2024 was -43.06 million yuan, worsening from -10.62 million yuan in 2023 [3] IPO and Fundraising - The company was listed on the Sci-Tech Innovation Board on March 14, 2022, with an initial public offering of 16.67 million shares at a price of 65.65 yuan per share [4] - The total amount raised from the IPO was 1.094 billion yuan, with a net amount of 975 million yuan after deducting issuance costs, exceeding the original plan by 418 million yuan [4] - The funds raised are intended for expansion projects, research and development center construction, and operational funding [4] Underwriter and Strategic Placement - The total issuance costs amounted to 119 million yuan, with the underwriter, Minsheng Securities, receiving 93.02 million yuan in underwriting fees [5] - The strategic placement involved Minsheng Investment, a subsidiary of the underwriter, which subscribed to 4% of the shares, amounting to 4.38 million yuan [5]